2024
DOI: 10.1001/jamadermatol.2023.5425
|View full text |Cite
|
Sign up to set email alerts
|

Factors Affecting Treatment Selection Among Patients With Hidradenitis Suppurativa

Nicole Salame,
Yacine N. Sow,
Meron R. Siira
et al.

Abstract: ImportanceDespite the US Food and Drug Administration’s approval of adalimumab for the treatment of hidradenitis suppurativa (HS), prescription rates remain low, indicating a critical gap between evidence-based guidelines and clinical practice. Understanding the medical decision-making process that these patients use when considering biologic agents and other HS therapies may uncover opportunities for improved patient-physician communication and HS disease control.ObjectiveTo elucidate factors that affect the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 36 publications
0
0
0
Order By: Relevance